Effects of Pericapsular Nerve Group Block on Postoperative Recovery for Total Hip Arthroplasty

StatusCompleted
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed
    • Eligibility criteria expanded, about 9 words
    • Site details revised
  2. Study completion date: Jul 30, 2025 to Dec 30, 2025v7
  3. Study completion date: Dec 8, 2024 to Jul 30, 2025v6
  4. Primary completion date: Mar 31, 2024 to Oct 10, 2024
    • Study completion date: Aug 8, 2024 to Dec 8, 2024
    v5
  5. Study completion date: Jun 8, 2024 to Aug 8, 2024v4
Show 2 earlier versionsHide 2 earlier versions
  1. Study completion date: May 8, 2024 to Jun 8, 2024v3
  2. Primary completion date changed from estimate of Jan 31, 2024 to Mar 31, 2024
    • Study completion date: Mar 31, 2024 to May 8, 2024
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The hypothesis of this study is that patients who undergo PENG block in before Total Hip Artroplasthy (THA) surgery with spinal anesthesia will have reduced postoperative pain scores, less need for opioid analgesics and earlier mobilisation.
Trial Details
NCT Number NCT06183528
Lead Sponsor Umraniye Education and Research Hospital
Conditions
(from sponsor)		 Analgesia, Postoperative Pain, Acute
Related terms Agnosia, Postoperative Pain
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov